We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current IRWD market cap is 288.05M. The company's latest EPS is USD -6.2629 and P/E is -0.29.
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 113.74M | 117.55M | 74.88M | 94.4M | 91.59M |
| Operating Income | 40.02M | 37.59M | 11.02M | 24.98M | 25.64M |
| Net Income | 15.32M | -1.09M | -4.16M | -860k | 3.65M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 431.94M | 389.52M | 413.8M | 410.6M | 442.74M |
| Operating Income | 116.95M | 142.94M | 232.26M | 250.34M | -945.43M |
| Net Income | 21.51M | 106.18M | 528.45M | 175.07M | -1B |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 524.06M | 471.07M | 438.82M | 395.62M | 389.52M |
| Total Liabilities | 849.74M | 817.37M | 769.34M | 717.35M | 700.85M |
| Total Equity | -325.68M | -346.3M | -330.52M | -321.73M | -311.33M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 402.75M | 559.24M | 1.13B | 1.1B | 471.07M |
| Total Liabilities | 496M | 496.6M | 521.02M | 448.14M | 817.37M |
| Total Equity | -93.25M | 62.64M | 605.91M | 652.38M | -346.3M |
| Quarter End | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 147.59M | 183.43M | 44.99M | 78.45M | 88.34M |
| Investing | -1.02B | -1.03B | -68k | -126k | -142k |
| Financing | 328.06M | 277.16M | -15.56M | -64.93M | -92.08M |
| Year End December 30 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | 10.73M | 168.84M | 261.9M | 273.76M | 183.43M |
| Investing | -11.14M | -1.84M | -265k | -136k | -1.03B |
| Financing | -1.19M | 18.55M | -4.55M | -237.55M | 277.16M |
| Market Cap | 288.05M |
| Price to Earnings Ratio | -0.29 |
| Price to Sales Ratio | 0.65 |
| Price to Cash Ratio | 3.13 |
| Price to Book Ratio | -0.83 |
| Dividend Yield | - |
| Shares Outstanding | 160.03M |
| Average Volume (1 week) | 2.11M |
| Average Volume (1 Month) | 5.01M |
| 52 Week Change | -87.97% |
| 52 Week High | 15.26 |
| 52 Week Low | 1.59 |
| Spread (Intraday) | 0.09 (4.86%) |
| Company Name | Ironwood Pharmaceuticals Inc |
| Address |
1209 orange street wilmington, delaware 19801 |
| Website | https://www.ironwoodpharma.com |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
